American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes
The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have evaluated the role of hemoglobin A1c (A1C) for the diagnosis of type 2 diabetes. The American Diabetes Association 2010 Clinical Practice Recommendations endorse the use of A1C of 6.5% o...
Gespeichert in:
| Veröffentlicht in: | Endocrine practice 2010-03, Vol.16 (2), p.155-156 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 156 |
|---|---|
| container_issue | 2 |
| container_start_page | 155 |
| container_title | Endocrine practice |
| container_volume | 16 |
| creator | American College of Endocrinologists Board of Trustees American Association of Clinical Endocrinologists Board of Directors |
| description | The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have evaluated the role of hemoglobin A1c (A1C) for the diagnosis of type 2 diabetes. The American Diabetes Association 2010 Clinical Practice Recommendations endorse the use of A1C of 6.5% or higher as the primary criterion for the diagnosis of diabetes. Such testing does not require the patient to be fasting, can be done at any time that a clinical visit is scheduled, is simpler to perform than the 2-hour oral glucose tolerance test, and is less dependent on the patient's health status at the time a blood sample is obtained. AACE/ACE do not endorse A1C criteria for prediabetes or for those patients at risk for diabetes. AACE/ACE do support an A1C of 5.5% to 6.4% as a screening test for prediabetes if it leads to measurement of a fasting glucose level or performance of a glucose tolerance test for diagnosis. |
| doi_str_mv | 10.4158/EP.16.2.155 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733403368</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733403368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c316t-fc1b06a1f90ab61d7a56a396e407450f72416b711e253ce5f96e07c034ff04f13</originalsourceid><addsrcrecordid>eNpd0btuHCEUBmAUJYodJ1X6aKQUKaJZc4bLzJSr1eYiWbKLWHKHGPawxmLAAabwm-Rxw64dK3LF5Xz8IA4hH4GuOIjhfHu1ArnqViDEK3IKI-Ntxyl7XeeC0XYY4eaEvMv5jtKOjjC8JScdZYKOFE7Jn_WMyRkdmnXO0ThdXAxNtM3Gu1D3fbMNu2iSC9HHvcslnz-f2ETvcY8H_T96aHLRBWcMpalZ5RabJR_VLc5x7-Pk6m1gGhvTsbpzeh9idvlg6mLCgvk9eWO1z_jhaTwj19-2vzY_2ovL7z8364vWMJCltQYmKjXYkepJwq7XQmo2SuS054LavuMgpx4AO8EMCltLtDeUcWspt8DOyJfH3PsUfy-Yi5pdNui9DhiXrHrG6mcyOVT5-YW8i0sK9XEK5DiM_cCFqOrrozIp5pzQqvvkZp0eFFB16JfaXlWvOgVH_ekpc5lm3D3bfw1ifwFbXJFc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1698978455</pqid></control><display><type>article</type><title>American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>American College of Endocrinologists Board of Trustees ; American Association of Clinical Endocrinologists Board of Directors</creator><creatorcontrib>American College of Endocrinologists Board of Trustees ; American Association of Clinical Endocrinologists Board of Directors</creatorcontrib><description>The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have evaluated the role of hemoglobin A1c (A1C) for the diagnosis of type 2 diabetes. The American Diabetes Association 2010 Clinical Practice Recommendations endorse the use of A1C of 6.5% or higher as the primary criterion for the diagnosis of diabetes. Such testing does not require the patient to be fasting, can be done at any time that a clinical visit is scheduled, is simpler to perform than the 2-hour oral glucose tolerance test, and is less dependent on the patient's health status at the time a blood sample is obtained. AACE/ACE do not endorse A1C criteria for prediabetes or for those patients at risk for diabetes. AACE/ACE do support an A1C of 5.5% to 6.4% as a screening test for prediabetes if it leads to measurement of a fasting glucose level or performance of a glucose tolerance test for diagnosis.</description><identifier>ISSN: 1530-891X</identifier><identifier>EISSN: 1934-2403</identifier><identifier>DOI: 10.4158/EP.16.2.155</identifier><identifier>PMID: 20350901</identifier><language>eng</language><publisher>United States: Elsevier Limited</publisher><subject>Diabetes Mellitus, Type 2 - diagnosis ; Endocrinology - standards ; Glycated Hemoglobin A - analysis ; Humans ; Societies, Medical - standards ; United States</subject><ispartof>Endocrine practice, 2010-03, Vol.16 (2), p.155-156</ispartof><rights>Copyright Allen Press Publishing Services Mar/Apr 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c316t-fc1b06a1f90ab61d7a56a396e407450f72416b711e253ce5f96e07c034ff04f13</citedby><cites>FETCH-LOGICAL-c316t-fc1b06a1f90ab61d7a56a396e407450f72416b711e253ce5f96e07c034ff04f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20350901$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>American College of Endocrinologists Board of Trustees</creatorcontrib><creatorcontrib>American Association of Clinical Endocrinologists Board of Directors</creatorcontrib><title>American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes</title><title>Endocrine practice</title><addtitle>Endocr Pract</addtitle><description>The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have evaluated the role of hemoglobin A1c (A1C) for the diagnosis of type 2 diabetes. The American Diabetes Association 2010 Clinical Practice Recommendations endorse the use of A1C of 6.5% or higher as the primary criterion for the diagnosis of diabetes. Such testing does not require the patient to be fasting, can be done at any time that a clinical visit is scheduled, is simpler to perform than the 2-hour oral glucose tolerance test, and is less dependent on the patient's health status at the time a blood sample is obtained. AACE/ACE do not endorse A1C criteria for prediabetes or for those patients at risk for diabetes. AACE/ACE do support an A1C of 5.5% to 6.4% as a screening test for prediabetes if it leads to measurement of a fasting glucose level or performance of a glucose tolerance test for diagnosis.</description><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Endocrinology - standards</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Humans</subject><subject>Societies, Medical - standards</subject><subject>United States</subject><issn>1530-891X</issn><issn>1934-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0btuHCEUBmAUJYodJ1X6aKQUKaJZc4bLzJSr1eYiWbKLWHKHGPawxmLAAabwm-Rxw64dK3LF5Xz8IA4hH4GuOIjhfHu1ArnqViDEK3IKI-Ntxyl7XeeC0XYY4eaEvMv5jtKOjjC8JScdZYKOFE7Jn_WMyRkdmnXO0ThdXAxNtM3Gu1D3fbMNu2iSC9HHvcslnz-f2ETvcY8H_T96aHLRBWcMpalZ5RabJR_VLc5x7-Pk6m1gGhvTsbpzeh9idvlg6mLCgvk9eWO1z_jhaTwj19-2vzY_2ovL7z8364vWMJCltQYmKjXYkepJwq7XQmo2SuS054LavuMgpx4AO8EMCltLtDeUcWspt8DOyJfH3PsUfy-Yi5pdNui9DhiXrHrG6mcyOVT5-YW8i0sK9XEK5DiM_cCFqOrrozIp5pzQqvvkZp0eFFB16JfaXlWvOgVH_ekpc5lm3D3bfw1ifwFbXJFc</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>American College of Endocrinologists Board of Trustees</creator><creator>American Association of Clinical Endocrinologists Board of Directors</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c316t-fc1b06a1f90ab61d7a56a396e407450f72416b711e253ce5f96e07c034ff04f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Endocrinology - standards</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Humans</topic><topic>Societies, Medical - standards</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>American College of Endocrinologists Board of Trustees</creatorcontrib><creatorcontrib>American Association of Clinical Endocrinologists Board of Directors</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><aucorp>American College of Endocrinologists Board of Trustees</aucorp><aucorp>American Association of Clinical Endocrinologists Board of Directors</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes</atitle><jtitle>Endocrine practice</jtitle><addtitle>Endocr Pract</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>16</volume><issue>2</issue><spage>155</spage><epage>156</epage><pages>155-156</pages><issn>1530-891X</issn><eissn>1934-2403</eissn><abstract>The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have evaluated the role of hemoglobin A1c (A1C) for the diagnosis of type 2 diabetes. The American Diabetes Association 2010 Clinical Practice Recommendations endorse the use of A1C of 6.5% or higher as the primary criterion for the diagnosis of diabetes. Such testing does not require the patient to be fasting, can be done at any time that a clinical visit is scheduled, is simpler to perform than the 2-hour oral glucose tolerance test, and is less dependent on the patient's health status at the time a blood sample is obtained. AACE/ACE do not endorse A1C criteria for prediabetes or for those patients at risk for diabetes. AACE/ACE do support an A1C of 5.5% to 6.4% as a screening test for prediabetes if it leads to measurement of a fasting glucose level or performance of a glucose tolerance test for diagnosis.</abstract><cop>United States</cop><pub>Elsevier Limited</pub><pmid>20350901</pmid><doi>10.4158/EP.16.2.155</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1530-891X |
| ispartof | Endocrine practice, 2010-03, Vol.16 (2), p.155-156 |
| issn | 1530-891X 1934-2403 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733403368 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Diabetes Mellitus, Type 2 - diagnosis Endocrinology - standards Glycated Hemoglobin A - analysis Humans Societies, Medical - standards United States |
| title | American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T11%3A06%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=American%20Association%20of%20Clinical%20Endocrinologists/American%20College%20of%20Endocrinology%20statement%20on%20the%20use%20of%20hemoglobin%20A1c%20for%20the%20diagnosis%20of%20diabetes&rft.jtitle=Endocrine%20practice&rft.aucorp=American%20College%20of%20Endocrinologists%20Board%20of%20Trustees&rft.date=2010-03-01&rft.volume=16&rft.issue=2&rft.spage=155&rft.epage=156&rft.pages=155-156&rft.issn=1530-891X&rft.eissn=1934-2403&rft_id=info:doi/10.4158/EP.16.2.155&rft_dat=%3Cproquest_cross%3E733403368%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1698978455&rft_id=info:pmid/20350901&rfr_iscdi=true |